From: Management of decision of withholding and withdrawing life-sustaining treatments in French EDs
N = 145 medical records | IC 95% | ||
---|---|---|---|
Collegiality of the decision-making process | |||
 ④ | Medical and paramedical collegial discussion | 60 (41.4%) | [33.7; 49.5] |
 ⑥ | An external medical consultant was associated to the collegial discussion | 57 (39.3%) | [31.7; 47.4] |
 ⑤ | The general practitioner of the patient was associated to the collegial discussion | 5 (3.4%) | [1.5; 7.8] |
Traceability | |||
 ①| Traceability of the medical decision context | 98 (67.6%) | [59.6; 74.7] |
 ③ | Traceability of the prognosis assessment | 53 (36.6%) | [29.2; 44.6] |
 ⑩ | Traceability of medical decision | 122 (84.1%) | [77.3; 89.2] |
 ⑪ | Traceability of therapeutic decisions after medical decision | 29 (20.0%) | [14.3; 27.2] |
 ⑫ | Traceability of the decision reevaluation | 34/50 (68.0%) | [54.2; 79.2] |
Management | |||
 ② | Evaluation of the autonomy level and the quality of life of the patient | 82 (56.6%) | [48.4; 64.3] |
 ⑬ | Evaluation of physical and mental pain | 43/134 (32.1%) | [24.8; 40.4] |
 ①| Management of pain and comfort care | 78/117 (66.7%) | [57.7; 74.6] |
Communication | |||
 ⑦ | Search for the patient’s will or advanced directives | 27 (18.6%) | [13.1; 25.7] |
 ⑧ | If the patient is unable to express his will, questioning of the trusted person, family or friends | 54/136 (39.7%) | [31.9; 48.1] |
 ⑨ | Information given to conscious patient about state of health or the relatives if the patient is unconscious patient | 111 (76.6%) | [69.0; 82.7] |
 ⑮ | Support for relatives | 2 (1.4%) | [0.4; 4.9] |